A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma

Cancer
Non Hodgkin Lymphoma (NHL)
Diffuse Large B-Cell Lymphoma (DLBCL)
B-cell Non-Hodgkin Lymphoma

Results
Download
Print

Study results

LPS GO40515 LUNSUMIO Final Results January 2025 English (PDF, 1.4 MB)

LPS GO40515 LUNSUMIO Final Results January 2025 Austria German (PDF, 1.5 MB)

LPS GO40515 LUNSUMIO Final Results January 2025 France French (PDF, 1.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma

Study results

LPS GO40515 LUNSUMIO Final Results January 2025 English (PDF, 1.4 MB)

LPS GO40515 LUNSUMIO Final Results January 2025 Austria German (PDF, 1.5 MB)

LPS GO40515 LUNSUMIO Final Results January 2025 France French (PDF, 1.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma

For the latest version of this information please go to www.forpatients.roche.com